108
Views
10
CrossRef citations to date
0
Altmetric
Editorial

Current challenges for the creation of effective vaccines against drugs of abuse

&
Pages 1637-1639 | Published online: 09 Jan 2014

References

  • Pleis JR, Ward BW, Lucas JW. Summary health statistics for U.S. adults: National health interview survey, 2009. National Center for Health Statistics. Vital Health Stat.10(249), 1–207 (2010).
  • US Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings NSDUH Series H-41 HHS Publication No. (SMA) 11–4658 (2011).
  • McLellan AT, Lewis DC, O’Brian CP, Kleber H. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. J. Am. Med. Assoc.284(13), 1689–1695 (2000).
  • Jorenby DE, Hays JT, Rigotti NA et al. Efficacy of varenicline, an a4b2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. J. Am. Med. Assoc.296, 56–63 (2006).
  • Hatsukami DK, Jorenby D, Gonzales D et al. Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin. Pharmacol. Ther.89(3), 392–399 (2011).
  • Martell BA, Orson FM, Poling J et al. Cocaine vaccine for the treament of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Arch. Gen. Psychiat.66(10), 1116–1123 (2009).
  • Carrera MR, Ashley JA, Wirsching P, Koob GF, Janda KD. A second-generation vaccine protects against the psychoactive effects of cocaine. Proc. Natl Acad. Sci.98, 1988–1992 (2001).
  • Stowe GN, Vendruscolo LF, Edwards S et al. A vaccine strategy that induces protective immunity against heroin. J. Med. Chem.54(14), 5195–5204 (2011).
  • Meijler MM, Matsushita H, Atobell LJ, Wirshing P, Janda KD. A new strategy for improved nicotine vaccines using conformationally constrained haptens. J. Am. Chem. Soc.125, 7164–7165 (2003).
  • Moreno AY, Mayorov AV, Janda KD. Impact of distinct chemical structures for the development of a methamphetamine vaccine. J. Am. Chem. Soc.133(17), 6587–6595 (2011).
  • Duryee MJ, Bevins RA, Reichel CM et al. Immune response to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines. Vaccine27, 2981–2988 (2009).
  • Carroll FI, Blough BE, Pidaparthi RR et al. Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines. J. Med. Chem.54(14), 5221–5228 (2011).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.